Consortium members demonstrate
expertise and historical success in:
Strategic
business planning and enterprise growth mechanisms
Identification
of future trends in the life sciences and relevant technologies
Design
of efficient and effective development strategies for early stage biomedical
products
Generation
of grants-based seed funding for product feasibility testing
Assessment
of the therapeutic and diagnostic potential of novel science
Effective
licensing and acquisition of technologies and nascent firms
Business
development and partnering
Corporate
capitalization, development, and governance
Competitive
assessment
New-product
conceptualization, commercialization, and marketing
Technology
management in life science businesses
Clients served by Consortium members include major pharmaceutical
and biotechnology companies, emerging life science firms, research and
diagnostic products companies, producers of laboratory equipment and supplies,
investors and intermediaries, and large professional service firms.
The Consortium combines the advantages of large and small consulting firms: expansive depth and breadth of experience without the training and overhead burdens associated with large, relatively junior staffs. Each engagement is strictly tailored to client needs and executed by one or more established experts in life science management and executive counsel. Capabilities in technology strategy and new-product commercialization distinguish the Consortium from most management consulting firms.
For descriptions of Biopharmaceutical Consortium member consultancies, please click here.
- ----------
Biopharmaceutical Consortium member consultancies
Haberman Associates home page
Copyright © 1999-2008 Haberman Associates